Expertise in
19
conditions

Dr. Fernando Bazan

Radiology
Christus Santa Rosa Hospital-New Braunfels
600 N Union Ave, 
New Braunfels, TX 
Accepting New Patients
Referral may be required
Before you request
Expertise in
19
conditions
Christus Santa Rosa Hospital-New Braunfels
600 N Union Ave, 
New Braunfels, TX 

Overview

Fernando Bazan is a Radiologist practicing medicine in New Braunfels, Texas.

Dr. Bazan is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Rhizarthrosis, Breast Lump, and CAPOS Syndrome.

He is actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 11 clinical trials. Dr. Bazan is currently accepting new patients.

Specialties

Radiology

Licenses

Diagnostic Radiology in TX

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Christus Santa Rosa Hospital-New Braunfels
600 N Union Ave, New Braunfels, TX 78130

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2026
Intervention Type: Drug
Study Drugs: tucatinib, T-DM1
Study Phase: Phase 3
Cohort Study to Evaluate the Clinical Features of Patients With Epithelial Ovarian Cancer Depending on Tumoral Mutation of BRCA or Beyond BRCA Genomic Molecular Abnormalities
Cohort Study to Evaluate the Clinical Features of Patients With Epithelial Ovarian Cancer Depending on Tumoral Mutation of BRCA or Beyond BRCA Genomic Molecular Abnormalities
Enrollment Status: Completed
Publish Date: June 08, 2026
A National, Multicenter, Randomized Controlled Trial to Assess the Efficacy of a Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Women With Metastatic Breast Cancer
A National, Multicenter, Randomized Controlled Trial to Assess the Efficacy of a Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Women With Metastatic Breast Cancer
Enrollment Status: Completed
Publish Date: May 04, 2026
Intervention Type: Device
Study Phase: Not Applicable
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Diagnostic test, Other
Study Phase: Not Applicable
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
De-Escalation of Adjuvant Chemotherapy in HER2-positive, Estrogen Receptor-negative, Node-negative Early Breast Cancer Patients Who Achieved Pathological Complete Response After Neoadjuvant Chemotherapy and Dual HER2 Blockade
De-Escalation of Adjuvant Chemotherapy in HER2-positive, Estrogen Receptor-negative, Node-negative Early Breast Cancer Patients Who Achieved Pathological Complete Response After Neoadjuvant Chemotherapy and Dual HER2 Blockade
Enrollment Status: Terminated
Publish Date: December 04, 2024
Intervention Type: Drug
Study Phase: Phase 2
Phase 2 Study of MCLA-128-based Combinations in Metastatic Breast Cancer (MBC): MCLA-128/Trastuzumab/Chemotherapy in HER2-positive MBC and MCLA-128/Endocrine Therapy in Estrogen Receptor Positive and Low HER2 Expression MBC
Phase 2 Study of MCLA-128-based Combinations in Metastatic Breast Cancer (MBC): MCLA-128/Trastuzumab/Chemotherapy in HER2-positive MBC and MCLA-128/Endocrine Therapy in Estrogen Receptor Positive and Low HER2 Expression MBC
Enrollment Status: Completed
Publish Date: March 07, 2024
Intervention Type: Drug
Study Drugs: MCLA-128, Trastuzumab, Vinorelbine, Endocrine Therapy
Study Phase: Phase 2
A Multicentric, Randomized, Non Comparative, Open-label Phase I/II Evaluating AZD2014 (Dual Mammalian Target of Rapamycin Complex 1/2 (mTORC1/mTORC2) Inhibitor) in Combination With Anastrozole Versus Anastrozole Alone in the Treatment of Metastatic Hormone Receptor-positive Endometrial Adenocarcinoma
A Multicentric, Randomized, Non Comparative, Open-label Phase I/II Evaluating AZD2014 (Dual Mammalian Target of Rapamycin Complex 1/2 (mTORC1/mTORC2) Inhibitor) in Combination With Anastrozole Versus Anastrozole Alone in the Treatment of Metastatic Hormone Receptor-positive Endometrial Adenocarcinoma
Enrollment Status: Unknown
Publish Date: February 13, 2024
Intervention Type: Drug
Study Drugs: AZD2014, Anastrozole
Study Phase: Phase 1/Phase 2
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
Enrollment Status: Unknown
Publish Date: December 07, 2023
Intervention Type: Biological
Observational Retrospective Cohort Study in Patients With Relapsed Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Treated With Olaparib Following Response to Platinium-based Chemotherapy
Observational Retrospective Cohort Study in Patients With Relapsed Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Treated With Olaparib Following Response to Platinium-based Chemotherapy
Enrollment Status: Completed
Publish Date: September 06, 2023
Intervention Type: Drug
View 9 Less Clinical Trials

45 Total Publications

Germline BRCA1/2 Mutations in a Large Clinic-Based Cohort of Patients with Metastatic Breast Cancer in France.
Germline BRCA1/2 Mutations in a Large Clinic-Based Cohort of Patients with Metastatic Breast Cancer in France.
Journal: Cancers
Published: January 22, 2026
Similar Doctors
Expertise in
33
conditions
Expertise in
33
conditions
Referral may be required
Before you request

Office

8401 Datapoint Dr Ste 600, 
San Antonio, TX 
 (30.6 miles away)
210-616-7796
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Garrett Andersen is a Radiologist practicing medicine in San Antonio, Texas. Dr. Andersen is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Visceromegaly, Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 3, and Gastrostomy. Dr. Andersen is currently accepting new patients.

Expertise in
33
conditions
Expertise in
33
conditions
Referral may be required
Before you request

Office

155 E Sonterra Blvd Ste 100, 
San Antonio, TX 
 (23.2 miles away)
210-617-9500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Justin Boatsman is a Radiologist practicing medicine in San Antonio, Texas. Dr. Boatsman is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Osteopenia, Melorheostosis, Melorheostosis with Osteopoikilosis, Breast Lump, and Gastrostomy. Dr. Boatsman is currently accepting new patients.

Expertise in
53
conditions
Expertise in
53
conditions
Referral may be required
Before you request

Office

4383 Medical Dr Ste 150, 
San Antonio, TX 
 (30.6 miles away)
210-616-7796
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Jorge Velez is a Radiologist practicing medicine in San Antonio, Texas. Dr. Velez is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Ascites, Lymphofollicular Hyperplasia, Pleural Effusion, Gastrostomy, and Bone Marrow Aspiration. Dr. Velez is currently accepting new patients.

Frequently Asked Questions about Dr. Fernando Bazan

How do I make an appointment with Dr. Fernando Bazan?

You can book an appointment with Dr. Fernando Bazan by calling their office at 830-643-6162. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Fernando Bazan a top-rated expert for Pleural Effusion?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Fernando Bazan is classified as an Advanced expert for Pleural Effusion, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Fernando Bazan specialize in?

While Dr. Fernando Bazan is a Radiology, they have specific expertise in Pleural Effusion, Rhizarthrosis, and Breast Lump. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiology.

Does Dr. Fernando Bazan participate in research or clinical trials?

Yes. Dr. Fernando Bazan has published 45 articles and abstracts on conditions like Pleural Effusion. You can view a list of Dr. Fernando Bazan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Fernando Bazan accept my insurance?

Dr. Fernando Bazan accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 830-643-6162 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bazan's expertise for a condition
ConditionClose
      View All 19 Advanced Conditions
      View All 67 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile